The pharmaceutical company Merck & Co., Inc was at the 14th International Headache Congress in September, talking again about the migraine drug Telcagepant. And hopes that Telcagepant will see the light of day aren’t dead yet.
After concerns about using Telcagepant as a migraine preventative, Merck has moved ahead with trials using the new drug as [...]
{ 4 comments }


